{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:41:26Z","timestamp":1792644086556,"version":"4.5.0"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004006","name":"Istanbul University Scientific Research Projects Unit","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002657","name":"Istanbul \u00dcniversitesi","doi-asserted-by":"publisher","award":["36598"],"award-info":[{"award-number":["36598"]}],"id":[{"id":"10.13039\/501100002657","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004410","name":"Scientific and Technological Research Council of Turkey","doi-asserted-by":"publisher","award":["122S051"],"award-info":[{"award-number":["122S051"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejmech.2026.119328","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:25:51Z","timestamp":1789665951000},"page":"119328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Novel 1-benzyl-oxindole indole hybrids targeting PDGFR-\u03b2, SRC, and c-MET signaling and inducing caspase-3-dependent apoptosis in pancreatic cancer cells"],"prefix":"10.1016","volume":"320","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5625-0189","authenticated-orcid":false,"given":"Tu\u011f\u00e7e","family":"Cinek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merve","family":"Yildirim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6k\u00e7e","family":"Cihan-\u00dcst\u00fcnda\u011f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9805-2663","authenticated-orcid":false,"given":"Oykum","family":"Genc Akar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serap","family":"Sancar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayse","family":"Erol-Bozkurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcne\u015f","family":"\u00d6zen-Ero\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Begum","family":"Kucuker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8515-8338","authenticated-orcid":false,"given":"Fusun","family":"Oztay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serap","family":"Kuruca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sehnaz","family":"Bolkent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilg\u00fcn","family":"Karal\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejmech.2026.119328_bib1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.7150\/ijms.1.101","article-title":"Tyrosine kinase: role and significance in cancer","volume":"1","author":"Paul","year":"2004","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.ejmech.2026.119328_bib2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1478-811X-11-97","article-title":"Targeting the PDGF signaling pathway in tumor treatment","volume":"11","author":"Heldin","year":"2013","journal-title":"Cell Commun. Signal."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119328_bib3","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/path.5152","article-title":"Targeting PDGF-mediated recruitment of pericytes blocks vascular mimicry and tumor growth","volume":"246","author":"Thijssen","year":"2018","journal-title":"J. Pathol."},{"key":"10.1016\/j.ejmech.2026.119328_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114491","article-title":"New insights about the PDGF\/PDGFR signaling pathway as a promising target to develop cancer therapeutic strategies","volume":"161","author":"Pandey","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"Suppl 1","key":"10.1016\/j.ejmech.2026.119328_bib5","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/modpathol.2013.173","article-title":"Gastrointestinal stromal tumors: what do we know now?","volume":"27","author":"Corless","year":"2014","journal-title":"Mod. Pathol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119328_bib6","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1476-4598-12-94","article-title":"Non-small cell lung cancer cells surviving ionizing radiation treatment display cancer stem cell and epithelial\u2013mesenchymal transition phenotypes","volume":"12","author":"Gomez-Casal","year":"2013","journal-title":"Mol. Cancer"},{"issue":"8","key":"10.1016\/j.ejmech.2026.119328_bib7","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s00268-016-3477-2","article-title":"Impact of p53 and PDGFR-\u03b2 expression on metastasis and prognosis of patients with pancreatic cancer","volume":"40","author":"Kurahara","year":"2016","journal-title":"World J. Surg."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119328_bib8","doi-asserted-by":"crossref","first-page":"108","DOI":"10.5301\/JBM.2011.8322","article-title":"Coexpression of PDGFR-alpha, PDGFR-beta and VEGF as a prognostic factor in patients with hepatocellular carcinoma","volume":"26","author":"Chen","year":"2011","journal-title":"Int. J. Biol. Markers"},{"key":"10.1016\/j.ejmech.2026.119328_bib9","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.critrevonc.2018.08.002","article-title":"The role of PDGF-B\/PDGFR-\u03b2 axis in the normal development and carcinogenesis of the breast","volume":"131","author":"Jitariu","year":"2018","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"6","key":"10.1016\/j.ejmech.2026.119328_bib10","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nrd2530","article-title":"Drug development of MET inhibitors: targeting oncogene addiction and expedience","volume":"7","author":"Comoglio","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"issue":"12","key":"10.1016\/j.ejmech.2026.119328_bib11","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1158\/1078-0432.CCR-06-0818","article-title":"Targeting the c-Met signaling pathway in cancer","volume":"12","author":"Peruzzi","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"1 Suppl","key":"10.1016\/j.ejmech.2026.119328_bib12","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1177\/1758834011422556","article-title":"An overview of the c-MET signaling pathway","volume":"3","author":"Organ","year":"2011","journal-title":"Ther. Adv. Med. Oncol."},{"issue":"48","key":"10.1016\/j.ejmech.2026.119328_bib13","doi-asserted-by":"crossref","first-page":"7906","DOI":"10.1038\/sj.onc.1208160","article-title":"Src family kinases: key regulators of signal transduction","volume":"23","author":"Parsons","year":"2004","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.ejmech.2026.119328_bib14","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2147\/tcrm.2007.3.2.341","article-title":"Sunitinib: a novel tyrosine kinase inhibitor. A brief review of its therapeutic potential in the treatment of renal carcinoma and gastrointestinal stromal tumors (GIST)","volume":"3","author":"Le Tourneau","year":"2007","journal-title":"Therapeut. Clin. Risk Manag."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119328_bib15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1634\/theoncologist.2016-0197","article-title":"Sunitinib: ten years of successful clinical use and study in advanced renal cell carcinoma","volume":"22","author":"Motzer","year":"2017","journal-title":"Oncologist"},{"issue":"5","key":"10.1016\/j.ejmech.2026.119328_bib16","doi-asserted-by":"crossref","first-page":"24","DOI":"10.29245\/2578-2967\/2018\/5.1153","article-title":"Pyrrole indolin-2-one based kinase inhibitors as anti-cancer agents","volume":"2","author":"Yang","year":"2018","journal-title":"J. Cancer Treat. Diagn."},{"key":"10.1016\/j.ejmech.2026.119328_bib17","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4236\/pp.2012.31010","article-title":"Indolin-2-ones in clinical trials as potential kinase inhibitors: a review","volume":"3","author":"Prakash","year":"2012","journal-title":"Pharmacol. Pharm."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119328_bib18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s40268-017-0221-9","article-title":"Efficacy and safety of nintedanib for the treatment of idiopathic pulmonary fibrosis: an update","volume":"18","author":"Rodr\u00edguez-Portal","year":"2018","journal-title":"Drugs R&D"},{"key":"10.1016\/j.ejmech.2026.119328_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202000022","article-title":"Structure\u2013activity relationship studies of indolin-2-one derivatives as vascular endothelial growth factor receptor inhibitors and anticancer agents","volume":"353","author":"Yousefian","year":"2020","journal-title":"Arch. Pharmazie"},{"key":"10.1016\/j.ejmech.2026.119328_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113334","article-title":"Structural insights of oxindole-based kinase inhibitors as anticancer agents: recent advances","volume":"216","author":"Dhokne","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119328_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.131280","article-title":"Logical synthetic strategies and structure\u2013activity relationship of indolin-2-one hybrids as small-molecule anticancer agents: an overview","volume":"1247","author":"Chaudhari","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2026.119328_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202405357","article-title":"Oxindole: an anticancer scaffold\u2014Overview of the studies and approaches (2017\u20132024)","volume":"10","author":"Koulani","year":"2025","journal-title":"ChemistrySelect"},{"issue":"9","key":"10.1016\/j.ejmech.2026.119328_bib23","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1182\/blood-2002-07-2307","article-title":"SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo","volume":"101","author":"O'Farrell","year":"2003","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.ejmech.2026.119328_bib24","doi-asserted-by":"crossref","first-page":"8140","DOI":"10.1021\/jm101036c","article-title":"Novel potent orally active multitargeted receptor tyrosine kinase inhibitors: synthesis, structure\u2013activity relationships, and antitumor activities of oxindole derivatives","volume":"53","author":"Cho","year":"2010","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119328_bib25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.bmcl.2003.09.069","article-title":"Design and synthesis of aminopropyl tetrahydroindole-based indolin-2-ones as selective and potent inhibitors of Src and yes tyrosine kinase","volume":"14","author":"Guan","year":"2004","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"11","key":"10.1016\/j.ejmech.2026.119328_bib26","doi-asserted-by":"crossref","first-page":"4968","DOI":"10.1016\/j.ejmech.2010.08.004","article-title":"Synthesis and evaluation of indole, pyrazole, chromone and pyrimidine based conjugates for tumor growth inhibitory activities: development of highly efficacious cytotoxic agents","volume":"45","author":"Singh","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119328_bib27","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ejmech.2014.04.004","article-title":"Substituted E-3-(3-indolylmethylene)-1,3-dihydroindol-2-ones with antiproliferative activity: study of the effects on HL-60 leukemia cells","volume":"79","author":"Leoni","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119328_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108203","article-title":"New oxindole\u2013indole hybrid compounds carrying a benzoyl moiety as tyrosine kinase inhibitors","volume":"156","author":"Camc\u0131-Eren","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119328_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118509","article-title":"Novel 1-benzyl-oxindole indole hybrids as tyrosine kinase inhibitors: design, synthesis, and biological activity evaluation","volume":"304","author":"Cihan-\u00dcst\u00fcnda\u011f","year":"2026","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119328_bib30","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41392-020-00361-x","article-title":"Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy","volume":"5","author":"Carter","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejmech.2026.119328_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.112025","article-title":"Dual-target kinase drug design: current strategies and future directions in cancer therapy","volume":"188","author":"Sun","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"19","key":"10.1016\/j.ejmech.2026.119328_bib32","doi-asserted-by":"crossref","first-page":"16532","DOI":"10.1021\/acsomega.3c00222","article-title":"Single inhibitors versus dual inhibitors: role of HDAC in cancer","volume":"8","author":"Roy","year":"2023","journal-title":"ACS Omega"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119328_bib33","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/s41392-022-01110-y","article-title":"Regulated cell death (RCD) in cancer: key pathways and targeted therapies","volume":"7","author":"Peng","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119328_bib34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/sci4020015","article-title":"Apoptosis and pharmacological therapies for targeting thereof for cancer therapeutics","volume":"4","author":"Singh","year":"2022","journal-title":"Science"},{"issue":"14","key":"10.1016\/j.ejmech.2026.119328_bib35","doi-asserted-by":"crossref","DOI":"10.1172\/JCI179570","article-title":"Targeting apoptotic pathways for cancer therapy","volume":"134","author":"Tian","year":"2024","journal-title":"J. Clin. Investig."},{"issue":"22","key":"10.1016\/j.ejmech.2026.119328_bib36","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.3390\/cells13221838","article-title":"Apoptosis: a comprehensive overview of signaling pathways, morphological changes, and physiological significance and therapeutic implications","volume":"13","author":"Mustafa","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2026.119328_bib37","unstructured":"Karal\u0131, N, Cihan-\u00dcst\u00fcndag, G, New 3-arylidene-oxindole DerivativesTR 2020 04769 B."},{"key":"10.1016\/j.ejmech.2026.119328_bib38","doi-asserted-by":"crossref","first-page":"5953","DOI":"10.3390\/ijms27135953","article-title":"The effect of radiofrequency exposure on the cytotoxic activity of sunitinib and a novel sunitinib-class compound 4, in colorectal cancer cells","volume":"27","author":"Erol-Bozkurt","year":"2026","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.ejmech.2026.119328_bib39","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","article-title":"Targeting apoptosis in cancer therapy","volume":"17","author":"Carneiro","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"Suppl 1","key":"10.1016\/j.ejmech.2026.119328_bib40","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/01.cad.0000361534.44052.c5","article-title":"Understanding the molecular-based mechanism of action of the tyrosine kinase inhibitor sunitinib","volume":"21","author":"Mena","year":"2010","journal-title":"Anti Cancer Drugs"},{"issue":"9","key":"10.1016\/j.ejmech.2026.119328_bib41","doi-asserted-by":"crossref","first-page":"E1465","DOI":"10.1210\/jc.2013-1364","article-title":"Antiproliferative and proapoptotic activity of sunitinib on endothelial and anaplastic thyroid cancer cells via inhibition of Akt and ERK1\/2 phosphorylation and by down-regulation of cyclin-D1","volume":"98","author":"Di Desidero","year":"2013","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119328_bib42","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.devcel.2011.06.017","article-title":"Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics","volume":"19","author":"Martinou","year":"2011","journal-title":"Dev. Cell"},{"issue":"6","key":"10.1016\/j.ejmech.2026.119328_bib43","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/s12276-025-01470-9","article-title":"Caspases as master regulators of programmed cell death: apoptosis, pyroptosis and beyond","volume":"57","author":"Dho","year":"2025","journal-title":"Exp. Mol. Med."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119328_bib44","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021108690","article-title":"BCL-2-family protein tBID can act as a BAX-like effector of apoptosis","volume":"41","author":"Flores-Romero","year":"2022","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119328_bib46","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12029-025-01183-2","article-title":"Trends in the global incidence of pancreatic cancer and a brief review of its histologic and molecular subtypes","volume":"56","author":"Leiphrakpam","year":"2025","journal-title":"J. Gastrointest. Cancer"},{"issue":"10","key":"10.1016\/j.ejmech.2026.119328_bib48","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.3390\/cancers17101607","article-title":"Unraveling the burden of pancreatic cancer in the 21st century: trends in incidence, mortality, survival, and key contributing factors","volume":"17","author":"Zottl","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.ejmech.2026.119328_bib49","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1053\/j.gastro.2011.08.009","article-title":"c-Met is a marker of pancreatic cancer stem cells and therapeutic target","volume":"141","author":"Li","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejmech.2026.119328_bib50","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3349\/ymj.2018.59.6.727","article-title":"Synergistic anti-cancer effects of AKT and Src inhibition in human pancreatic cancer cells","volume":"59","author":"Ahn","year":"2018","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.ejmech.2026.119328_bib51","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3892\/or.2020.7859","article-title":"Platelet-derived growth factor-BB mediates pancreatic cancer malignancy via regulation of the Hippo\/yes-associated protein signaling pathway","volume":"45","author":"Li","year":"2021","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ejmech.2026.119328_bib52","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/bs.acr.2022.01.003","article-title":"Diverse roles of tumor-stromal PDGFB-to-PDGFR\u03b2 signaling in breast cancer growth and metastasis","volume":"154","author":"Shah","year":"2022","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.ejmech.2026.119328_bib53","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1038\/s41416-024-02875-5","article-title":"The SRC-family serves as a therapeutic target in triple negative breast cancer with acquired resistance to chemotherapy","volume":"131","author":"Egeland","year":"2024","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejmech.2026.119328_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.crphar.2024.100204","article-title":"Targeting c-Met in breast cancer: from mechanisms of chemoresistance to novel therapeutic strategies","volume":"7","author":"Iweala","year":"2024","journal-title":"Curr. Res. Pharmacol. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.119328_bib55","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1158\/1078-0432.CCR-05-1571","article-title":"Phase I trial of sorafenib and gemcitabine in advanced solid tumors with an expanded cohort in advanced pancreatic cancer","volume":"12","author":"Siu","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.ejmech.2026.119328_bib56","first-page":"4899","article-title":"Sunitinib inhibits breast cancer cell proliferation by inducing apoptosis, cell-cycle arrest and DNA repair while inhibiting NF-\u03baB signaling pathways","volume":"37","author":"Korashy","year":"2017","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejmech.2026.119328_bib57","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11523-020-00784-0","article-title":"Updated efficacy and safety outcomes for patients with well-differentiated pancreatic neuroendocrine tumors treated with sunitinib","volume":"16","author":"Fazio","year":"2021","journal-title":"Targeted Oncol."},{"key":"10.1016\/j.ejmech.2026.119328_bib58","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-17333-6","article-title":"Oral sorafenib-loaded microemulsion for breast cancer: evidences from the in-vitro evaluations and pharmacokinetic studies","volume":"12","author":"Chaurawal","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.119328_bib59","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ymthe.2022.11.004","article-title":"Imatinib facilitates gemcitabine sensitivity by targeting epigenetically activated PDGFC signaling in pancreatic cancer","volume":"31","author":"Shi","year":"2023","journal-title":"Mol. Ther."},{"issue":"11","key":"10.1016\/j.ejmech.2026.119328_bib60","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.7291","article-title":"Targeting the core program of metastasis with a novel drug combination","volume":"13","author":"Fnu","year":"2024","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119328_bib61","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12935-023-03195-z","article-title":"Targeting HER2-positive breast cancer cells by a combination of dasatinib and BMS-202: insight into the molecular pathways","volume":"24","author":"Kheraldine","year":"2024","journal-title":"Cancer Cell Int."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119328_bib62","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/mc.23848","article-title":"Imatinib impedes EMT and Notch signalling by inhibiting p300 acetyltransferase in breast cancer cells","volume":"64","author":"Sarkar","year":"2025","journal-title":"Mol. Carcinog."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119328_bib63","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.clbc.2021.05.009","article-title":"A phase II study evaluating the safety and efficacy of sunitinib malate in combination with weekly paclitaxel followed by doxorubicin and daily oral cyclophosphamide plus G-CSF as neoadjuvant chemotherapy for locally advanced or inflammatory breast cancer","volume":"22","author":"Symonds","year":"2022","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.ejmech.2026.119328_bib64","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/jcb.10287","article-title":"Frequent activation of AKT2 kinase in human pancreatic carcinomas","volume":"87","author":"Altomare","year":"2002","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ejmech.2026.119328_bib65","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.canlet.2019.05.025","article-title":"AKT and ERK dual inhibitors: the way forward","volume":"459","author":"Cao","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejmech.2026.119328_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109383","article-title":"Inhibition of AKT enhances the anti-cancer effects of artemisinin in clear cell renal cell carcinoma","volume":"118","author":"Yu","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2026.119328_bib67","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.3390\/cancers13123026","article-title":"MAPK\/ERK signaling pathway in hepatocellular carcinoma","volume":"13","author":"Moon","year":"2021","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.ejmech.2026.119328_bib68","doi-asserted-by":"crossref","DOI":"10.1002\/cbf.3998","article-title":"The PI3K\/AKT\/mTOR signaling pathway in breast cancer: review of clinical trials and latest advances","volume":"42","author":"Khorasani","year":"2024","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.ejmech.2026.119328_bib69","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.taap.2013.01.011","article-title":"Inhibition of AKT enhances mitotic cell apoptosis induced by arsenic trioxide","volume":"267","author":"Yih","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119328_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103074","article-title":"Characteristic ERK1\/2 signaling dynamics distinguishes necroptosis from apoptosis","volume":"24","author":"Sipieter","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.ejmech.2026.119328_bib74","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3389\/fonc.2020.00552","article-title":"Activation of PDGFR-\u03b1\/AKT-mediated signaling pathways in oral squamous cell carcinoma by mesenchymal stem\/stromal cells promotes anti-apoptosis and decreased sensitivity to cisplatin","volume":"10","author":"Wang","year":"2020","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119328_bib75","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.leukres.2013.12.027","article-title":"Crizotinib (PF-2341066) induces apoptosis due to downregulation of pSTAT3 and BCL-2 family proteins in NPM-ALK(+) anaplastic large cell lymphoma","volume":"38","author":"Hamedani","year":"2014","journal-title":"Leuk. Res."},{"issue":"26","key":"10.1016\/j.ejmech.2026.119328_bib76","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1182\/blood-2015-07-658823","article-title":"Targeting HGF\/c-MET induces cell cycle arrest, DNA damage, and apoptosis for primary effusion lymphoma","volume":"126","author":"Dai","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2026.119328_bib77","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.toxlet.2018.05.033","article-title":"Inhibition of PDGFR by CP-673451 induces apoptosis and increases cisplatin cytotoxicity in NSCLC cells via inhibiting the Nrf2-mediated defense mechanism","volume":"295","author":"Yang","year":"2018","journal-title":"Toxicol. Lett."},{"issue":"11","key":"10.1016\/j.ejmech.2026.119328_bib78","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1158\/1535-7163.MCT-17-0417","article-title":"Combination therapy with c-Met and Src inhibitors induces caspase-dependent apoptosis of merlin-deficient Schwann cells and suppresses growth of Schwannoma cells","volume":"16","author":"Fuse","year":"2017","journal-title":"Mol. Cancer Therapeut."},{"issue":"7","key":"10.1016\/j.ejmech.2026.119328_bib79","doi-asserted-by":"crossref","DOI":"10.5040\/9781784602567","article-title":"c-Src binds to the cancer drug ruxolitinib with an active conformation","volume":"9","author":"Duan","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2026.119328_bib80","doi-asserted-by":"crossref","unstructured":"Liang, L., Yan, X. E., & Yun, C. H. (n.d.).Crystal structure of PDGFRA in complex with sunitinib by soaking (PDB ID: 6JOK). https:\/\/doi.org\/10.2210\/pdb6JOK\/pdb.","DOI":"10.2210\/pdb6jok\/pdb"},{"key":"10.1016\/j.ejmech.2026.119328_bib81","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1074\/jbc.M705774200","article-title":"c-Met inhibitors with novel binding mode show activity against several hereditary papillary renal cell carcinoma-related mutations","volume":"283","author":"Bellon","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.119328_bib82","doi-asserted-by":"crossref","first-page":"18872","DOI":"10.1021\/acsomega.0c02038","article-title":"Dual targeting of VEGFR2 and c-Met kinases via the design and synthesis of substituted 3-(triazolo-thiadiazin-3-yl)indolin-2-one derivatives as angiogenesis inhibitors","volume":"5","author":"Mohamady","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2026.119328_bib83","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2026.119328_bib84","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1367-5931(00)00226-X","article-title":"Drug delivery: an odyssey of 100 years","volume":"5","author":"Pillai","year":"2001","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119328_bib85","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s00044-010-9329-y","article-title":"Design, docking study and ADME prediction of isatin derivatives as anti-HIV agents","volume":"20","author":"Pawar","year":"2011","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2026.119328_bib86","doi-asserted-by":"crossref","first-page":"9889","DOI":"10.1016\/j.tet.2004.08.030","article-title":"Application of a catalytic palladium biaryl synthesis reaction via C\u2013H functionalization to the total synthesis of Amaryllidaceae alkaloids","volume":"60","author":"Torres","year":"2004","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2026.119328_bib87","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.1021\/jm0704189","article-title":"An investigation into the cytotoxicity and mode of action of some novel N-alkyl-substituted isatins","volume":"50","author":"Vine","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119328_bib88","series-title":"New 1-substituted 1H-indole-2,3-dione Compounds and Synthesis Methods (Turkish Patent No. TR 2015\/015912 B). Turkish Patent and Trademark Office","author":"Karal\u0131","year":"2015"},{"key":"10.1016\/j.ejmech.2026.119328_bib89","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1021\/ol800141t","article-title":"Palladium-catalyzed \u03b1-arylation of oxindoles","volume":"10","author":"Durbin","year":"2008","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2026.119328_bib90","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1039\/C8OB02859A","article-title":"Palladium-catalysed ring-opening [3+2]-annulation of spirovinylcyclopropyl oxindole to diastereoselectively access spirooxindoles","volume":"17","author":"Xiao","year":"2019","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2026.119328_bib91","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/j.bmc.2013.01.047","article-title":"Substituted indolin-2-ones as p90 ribosomal S6 protein kinase 2 (RSK2) inhibitors: molecular docking simulation and structure\u2013activity relationship analysis","volume":"21","author":"Zhong","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119328_bib92","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.bmc.2010.01.011","article-title":"Synthesis, structure\u2013activity relationship and crystallographic studies of 3-substituted indolin-2-one RET inhibitors","volume":"18","author":"Mologni","year":"2010","journal-title":"Bioorg. Med. Chem."},{"issue":"1\u20132","key":"10.1016\/j.ejmech.2026.119328_bib93","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"issue":"8","key":"10.1016\/j.ejmech.2026.119328_bib94","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/jcb.29920","article-title":"Effect of long noncoding RNAs on epithelial\u2013mesenchymal transition in A549 cells and fibrotic human lungs","volume":"122","author":"Yildirim","year":"2021","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ejmech.2026.119328_bib95","unstructured":"Schr\u00f6dinger Small-Molecule Drug Discovery Suite v.2025-2,Schr\u00f6dinger, LLC, New York, NY."},{"key":"10.1016\/j.ejmech.2026.119328_bib96","series-title":"Desmond Molecular Dynamics System","year":"2025"},{"key":"10.1016\/j.ejmech.2026.119328_bib97","series-title":"Schr\u00f6dinger Release 2025-2: Qikprop","year":"2025"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426007737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426007737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:27:10Z","timestamp":1792643230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426007737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":92,"alternative-id":["S0223523426007737"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119328","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel 1-benzyl-oxindole indole hybrids targeting PDGFR-\u03b2, SRC, and c-MET signaling and inducing caspase-3-dependent apoptosis in pancreatic cancer cells","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119328","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119328"}}